For Immediate Release
Seattle, WA -
Point B Inc., an integrated management consulting, venture investment firm and property development firm, announced Chief Executive Officer Mike Pongon has been appointed to the National Multiple Sclerosis Society National Board of Directors. In this role, he will help lead the Society’s efforts to create a world free of MS.
Pongon’s appointment extends a long history of dedication to and support of the mission of the MS Society. He is the former chair of the Society’s Oregon chapter, where he helped reinvigorate Bike MS and the annual gala and improve the financial success and volunteer leadership of the chapter. Pongon served on the National Metrics Advisory Committee and the West Region Volunteer Leadership Council, and has helped Point B secure a trustee and Bike MS team in each of the eight U.S. markets it serves. The firm has invested in and raised over $1.5 million for the MS Society over the past ten years.
“My enduring relationship with the MS Society has been quite important to me throughout my career,” said Mike Pongon. “Their bold vision and strategic approach to ending MS inspires me, and it’s an honor to be in a position to help influence positive outcomes for everyone living with MS.”
About the National MS Society
The Society mobilizes people and resources so that everyone affected by MS can live their best lives as we stop MS in its tracks, restore what has been lost and end MS forever. In 2014 alone, through our comprehensive nationwide network of programs and services, the Society devoted $122.2 million to connect more than one million individuals to the people, information and resources they need. To move closer to a world free of MS, the Society also invested $50.2 million to support more than 380 new and ongoing research projects around the world. We are united in our collective power to do something about MS now and end this disease forever. Learn more at www.nationalMSsociety.org.
About Multiple Sclerosis
Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million worldwide.